Reprogramming hiPSC and differentiation: Challenges in getting stable lines and good differentiating candidates for cell therapies explained. Produced by: ISCT Asia Regional Executive Committee Sponsored by: ...
ISCT Asia Regional Webinar I Reprogramming hiPSC and differentiation-20210326 0030-1.mp4
Webinar Description: Two speakers provide a comparative discussion on challenges in development and manufacturing for NK cell therapies. Our first speaker, based in the US, discusses the topic through examples of manufacturing for solid and hematological malignancies. Our second speaker brings...
3 attachments
By Joaquim Vives, PhD Banc de Sang i Teixits Barcelona, Spain Contributing editor Dr. Joaquim Vives provides his thoughts on an inspiring discussion started at ISCT 2021: The transformation of starting materials into safe and efficacious medicines involves numerous stakeholders and...
[Telegraft 28.3] - From the Editors.pdf
By Laarni Ibenana, MPS Project Manager Production Assistance for Cellular Therapies After 18 years of support from the National Heart, Lung, and Blood Institute (NHLBI), the Production Assistance for Cellular Therapies (PACT) program is coming to a close. We at the Telegraft would like...
[Telegraft 28.3] - PACT Update - June 2021.pdf
New at ISCT 2021 were the co-sponsored roundtable sessions on hot topics facing the cell and gene therapy industry. The sessions featured live discussion and Q&A from the audience, making for dynamic sessions tackling challenges to cell and gene therapy clinical translation. The Preparing...
ISCT 2021 - Future of CAR T Manufacturing Panel Abstract (1).pdf